IDXX — IDEXX Laboratories Inc · P/E 40, rev $2.36B

IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.

Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.

Use this IDXX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the IDXX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the IDXX SEC filings page. Lician reads the product cache first so this HTML stays unique to IDEXX Laboratories Inc even when a live quote feed is slow.

IDEXX Laboratories Inc latest statements (FY2025)

Latest cached year on this hub. Full IDXX income, balance, and cash tables.

  • Revenue$4.30B
  • Net Income$1.06B
  • Total Assets$3.35B
  • Total Debt$0
  • Free Cash Flow$1.06B

IDXX recent filings